Identification the Expression of Sox2 in Colorectal Cancer Tissues
NCT ID: NCT01589900
Last Updated: 2012-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
136 participants
OBSERVATIONAL
2005-01-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Second Primary Cancer and Early-onset Colorectal Cancer
NCT06423924
The Gene Profiles of Primary and Heterogeneous Metastases of Colorectal Cancer
NCT04230018
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients
NCT02022995
The Molecular Mechanism of RAS Wild-type mCRC Resistance to Anti-EGFR-antibody
NCT04466267
Significance of Cortactin Expression in Colorectal Adenocarcinomas
NCT05225870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
24 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lixiao Xu
Laboratory of Cancer and Stem Cell Biology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan Zhang, M.D.Ph.D
Role: PRINCIPAL_INVESTIGATOR
Laboratory of Cancer and Stem Cell Biology School of Life Sciences Sun Yat-sen University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SYSU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.